Presence of an in situ component is associated with reduced biological aggressiveness of size-matched invasive breast cancerHM Wong(Prince Philip Dental Hospital), Richard J. Epstein(Garvan Institute of Medical Research)British Journal of CancerApril 1, 201010.1038/sj.bjc.6605655Cited by 71SaveCiteExport RISWatch citationsRelated PapersHoarseness during treatment with bevacizumab and other vascular endothelial growth factor signalling inhibitors|Acta Oncologica|2009|4